Search

everythinglearnresearchcommunity

for

Search:↓

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Finasteride improves hair loss in women with hyperandrogenism.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.